©Novel Buddy
MTL - She is the Third Kind of Stunning-Chapter 60 science
Jian Qing observed the interface, found the microphone button, turned on the microphone and said: "I haven't played it before, it's better, please bear with me."
The cold voice came to his ears, and Lu Yinxi looked at the chat records on the chat interface
—Although she has never played before, her skills may be very good, but with my skills, I can definitely take her flying [expression cool]
—Just ask her, you said she might come to play with me...
A vivid interpretation of what is "confidence"...
Lu Yinxi rubbed the bridge of his nose, moved his thumb away from the microphone icon, did not dare to turn on the microphone, and looked around, trying to find a wall and find a crack to get in.
As soon as Wei Mingming heard his boss's voice, he quickly turned on his microphone to flatter him: "Boss, it's just for entertainment, as long as you have hands! Your voice is really nice! It's better than the CV voice in all the games I play! I've never heard it in my life." Had such a nice voice!"
Thousands of wears and thousands of wears, flattery does not wear.
Zhang Yue couldn't take it anymore: "That's enough, enough is enough, you haven't answered your boss's call? This is the first time you heard her talk?"
Wei Mingming yelled: "Can it be the same? This is the first time I played a game with my boss. I want to take a screenshot to commemorate it. By the way, I will post it on Moments to make my classmates envious. I have a beautiful, generous, approachable, and student and subordinate. Integral mentor."
The second half of the sentence is pure nonsense.
Zhao Wenqian opened the mic and joked: "Does that mean we have to set up a memorial day? Take this day every year to commemorate it?"
After finishing speaking, she and Zhang Yue both burst out laughing at the same time.
Jian Qing intentionally defended his shortcomings, and asked, "How does the game start?"
"Senior Sister, just follow that matching option later." Zhang Yue instructed Jian Qing to operate, and asked, "Xiaolu, where are you, Xiaolu? Why don't you use the microphone to communicate? Don't be shy if you're all on your own, isn't it convenient? If it is inconvenient to talk, please press 1 on the channel."
A suburban set.
Lu Yinxi stood in front of a concrete wall, scratched his arm that was bitten by mosquitoes, switched his phone to the chat software interface, and consciously sent a message to Jian Qing: [Doctor Jian, I thought about it while facing the wall. 】
She took a photo of the concrete wall and sent it, trying to get Jian Qing's forgiveness.
Jian Qing returned a smiling expression.
In the eyes of some elders, a smile has no yin and yang meaning, but simply expresses kindness.
But Jian Qing is obviously not at the age to be Lu Yinxi's elder.
She is just acting weird.
Lu Yinxi stared at that expression, pondered for a moment, and replied: [QAQ]
Play cute, show weakness.
Jian Qing replied: [Go back, there are many mosquitoes outside. 】
Mosquitoes in the suburbs are big and poisonous, and if bitten, they will swell up into a big bag.
Lu Yinxi patted the mosquito-bitten arm, walked back obediently, and sprayed some toilet water.
Jian Qing: [Open the microphone. 】
Lu Yinxi switched back to the game interface and turned on the team microphone: "Good evening, angels in white."
Wei Mingming's voice was a little excited: "Xiaolu, Xiaolu, if you play that Yao, it will become a deer Yao, suitable for you!"
Lu Yinxi refused: "No, I want to play jungle and take you away."
Zhao Wenqian said: "I haven't played much, I only know how to play shooter, and I like little Luban the most."
Zhang Yue said: "I can do it, I like pretty ones."
Wei Mingming said: "Xi Shi, Zhao Jun, Diao Chan, and Xiao Qiao, choose one of your four beauties, and I'll hit the road."
Jian Qing asked, "Which one is Yao?"
Zhang Yue said: "Senior sister, you click on the match first, Yao is this pink-haired loli with antlers."
Entering the hero selection interface of the game, Zhang Yue helped Jian Qing pick Yao out.
When Yao comes out, she will shout: "Become the light, because there are people who are afraid of the dark."
Jian Qing watched the animation of the characters appearing on the game interface, and was satisfied with seeing the bouncing deer transform into a cute little loli, and said lightly, "I use this."
Lu Yinxi said: "I will choose Yun Zhongjun, and you will jump on my head later to protect me."
Zhang Yue plays Xi Shi, Zhao Wenqian plays Lu Ban, and Wei Mingming plays Lu Bu.
After starting the game, walking out of the base camp, Jian Qing observed the character controlled by Lu Yinxi, and said, "Little bird man."
Yunzhongjun is a game character with a pair of big wings. In the game, He Yao is the official CP, the love of a bird and a deer.
Lu Yinxi manipulated the character, circling Jian Qing: "Follow me, when you reach level 4, you can press the third skill on your right, counting from left to right, to jump on my head, and then Randomly press the first and second skills, and you will run back when I am under siege, don't follow and give away the head."
Zhang Yue said: "Don't worry, Brother Zhang is in charge of on-site guidance."
Jian Qing knew nothing about the game, and the remaining four people were like serfs turning around and singing happily. This one taught the game operation, and the other popularized the game mechanism.
Jian Qing didn't put on airs of a superior in a field she wasn't familiar with, and listened carefully to their teachings.
Slowly, some clues can be sorted out.
She has a good comprehension ability and is quick to learn. Yao, a game character, is also easy to operate. In less than five minutes, she can proficiently cast skills and brush shields.
She doesn't have a lot of emotional ups and downs in the game, killing the hostile character is not necessarily very happy, and she doesn't complain when she is killed, and she calmly resurrects.
Very quiet.
Unlike Wei Mingming and Zhang Yue, Zhang Yue was fine in the hospital office, he just yelled "I'll go" a few times, and Wei Mingming's voice wanted to tear down the whole house.
Zhao Wenqian would keep chanting: "Protect our little Luban." "Eat me!" "Master Luban, IQ 250, Mobike, Mobike as soon as possible."
The three of them talked a lot, which made Lu Yinxi talk less.
Jian Qing asked her, "Why don't you speak?"
Lu Yinxi was afraid that if he talked too much, Jianqing would find it annoying in the noisy environment, so he put down his phone and kept silent.
When Jian Qing asked this question, she quickly said, "I'm here to arrest someone."
"I'll take you to fight Papa Lan on the opposite side. Lanlan's snare is on her body, it's very nice."
"This head is for you, hurry up and press the skill!"
Jian Qing quietly controls the game character, rides on the head of Luyinxi, follows her, and flies around the map.
Lu Yinxi looked at the phone screen with a smile on his lips.
The depression and depression have long been swept away,
When I met her, sadness and happiness became transient emotions.
After playing the game for half an hour, Jian Qing worked an extra half hour in the office.
When I got home, the house was empty.
Jian Qing put down her handbag, leaned on the sofa, closed her eyes and meditated.
At the entrance, the shoes are for two people; the walls of the living room are still hung with pendants; on the sofa, there are a few pillows and furry dolls; on the coffee table, there are fruit snacks she likes; The floor is paved with brocade bamboos, and the greenery is luxuriant.
There are traces of her everywhere in the house, but her person is not here, nor is her heart here.
Why do you always want to leave?
Can't figure it out.
The whole day's high-intensity work exhausted her energy, and Jian Qing had no energy left to think about it. She frowned and lay down on the sofa to take a nap.
After waking up after a short break, she started to prepare for going abroad.
This time I went abroad to participate in an international academic conference with the theme of lung cancer.
In recent years, the domestic oncology field has gathered a lot of brains to study immunotherapy. Seventy to eighty percent of the clinical trials in the oncology departments, radiotherapy departments, and hematology departments of major hospitals are all about immunotherapy.
What Hu Jianjun wants to report is also the results of a global multi-center, open, randomized controlled phase III clinical study of a certain PD1 drug.
Different from many domestic academic conferences set up for the purpose of mixing credits and expanding the influence of hospitals, almost all of the participants in this international conference are top scholars and teams engaged in lung cancer research and clinical work from various countries. Many studies at the conference are Clinical data published for the first time.
Jian Qing is responsible for organizing and translating the materials reported by scholars from various countries, learning the objective response rate, median progression-free survival period, and overall survival period under different treatment plans, and then making an academic report to doctors and students in hospitals and schools after returning to China .
At the China session, when Hu Jianjun was standing on the podium in a suit and leather shoes and reporting fluently, Zhang Yue snapped a few photos with his camera, and whispered in Jian Qing’s ear: “Our boss is so handsome! His red and expert speech at the leadership office meeting of the academy is much better!"
Usually in the courtyard, everyone calls Hu Jianjun, Deputy Hu, Hu Yuan, leader...
Doctoral advisors of his level accept students only by name, they don’t take them personally, they are handed over to the subordinates, so no one calls him “boss”.
This time when he went abroad, Zhang Yue yelled "Boss" on the plane, and Hu Jianjun felt strange.
Perhaps breaking away from the sense of hierarchy of the hospital, during the business trip, a few people don't talk about medicine, and exchange the customs of foreign countries in a harmonious manner, which feels more like a master's school.
Jian Qing replied to Zhang Yue, "When he became famous, you were still playing with mud."
Hu Jianjun has only been in the management of the hospital for a long time in recent years, and he is a little obsessed with administrative power struggles. His academic ability and scientific research achievements are still unmatched in the hospital.
At the end of the meeting in the afternoon, Hu Jianjun was interviewed by media reporters, while Jian Qing and Zhang Yue were waiting as assistants.
During the period, Jian Qing met her tutor when she was studying abroad, and was dragged to have a cup of coffee.
After Hu Jianjun came back, the leader of a certain domestic pharmaceutical company, who was also Hu Jianjun's classmate, invited them to go to a hotel for dining, shopping and tourism, but Hu Jianjun repeatedly refused.
In the end, a few members of the team randomly found a Chinese restaurant for dinner.
During the meal, Hu Jianjun did not forget to seriously teach a few students: "You will have many opportunities to go abroad in the future, so be cautious in your words and deeds, and don't be caught in the braid. A few years ago, when some experts and professors went abroad for a meeting, the medicine People from the company treat guests to dinner, travel and shop for free, and reimburse air tickets, and finally they are treated as bribery cases. Some classmates and alumni relationships must be handled with caution."
The people in the team nodded again and again.
"I've met quite a few old acquaintances in the past few days. I also met an old classmate in the morning. He invited me to their hospital in H City for an academic exchange. When we return to China, we will go to his place first." After Hu Jianjun finished speaking, he asked Jian Qing again, "Have you met your former mentor?"
Jian Qing nodded and said, "He is concerned about my recent situation."
She is a Ph.D. jointly trained by Jiang University and UC-B. She is awarded an MD degree abroad and a PhD degree in China. When she returned to China, her foreign supervisor wanted her to stay in her own laboratory. Hu Jianjun in China told her: "Science has no borders. Scientists have borders."
She returned home.
At the dinner table, someone suddenly talked about the price war of PD-1 drugs. Hu Jianjun emphasized again earnestly: "Science has no national boundaries, but scientists have national boundaries. Scholars from various countries share and exchange scientific research results at the conference today. There is no national border. Tomorrow, scientific research results will be transformed into For products, the country is used as the boundary to start a price struggle.”
A Ph.D. supervisor in epidemiology echoed: "Like the two foreign immunological drugs that first entered the Chinese market, O drug and K drug, cost more than 300,000 yuan a year in the first year. How many people can afford it?"
The fellow doctor of pharmacology said: "No way, it's not like you don't know that the cost of research and development is too high.
The research and development of anticancer drugs is divided into preclinical research and clinical trials. It takes more than ten years or decades before and after, and requires billions of capital investment.
In the research and development stage of a pharmaceutical company, nine times out of ten it is in a state of loss, and it can only rely on continuous drawing of big cakes to continue its life with investors.
Then the research and development is successful, the patent is applied for, and the market has the opportunity to monopolize. During the patent protection period, in order to ensure the return of costs and earn money, do you have to desperately raise the price?
Adding in the import tariffs, manpower, and material resources, it will become a sky-high price of medicine. "
The high price of drugs is due to the high cost of research and development, not the high price of raw materials.
Zhang Yue said: "If the medicines developed by ourselves in China were not included in the medical insurance, the overseas medicines would not drop so quickly."
In the year when O medicine and K medicine entered the Chinese market, the domestically produced PD-1 drug was launched, which fired the first shot in price counterattack, and then entered the medical insurance through price negotiation.
Imported pharmaceutical companies have not cut prices on the surface, but in order to compete for the Chinese market, they have adopted a policy of buying medicines and giving medicines to reduce prices in disguise.
Subsequently, with the continuous launch of domestic PD1 drugs, imported drugs have dropped from 300,000 a year at the beginning to less than 100,000 a year now.
There is no one who will not get sick. Not every ordinary family can afford hundreds of thousands of high medical expenses. When a serious illness strikes, there is no money to treat it without medicine, which is the most desperate thing.
If there is resistance from domestic medicines, domestic medicines will be included in the medical insurance, and the price of imported drugs will be forced to drop, or they will also strive to be included in the medical insurance.
Hu Jianjun said: "Being behind will be punished, not only at the national level, but also in any field. We do not have our own medicines, domestic original research medicines cannot stand up, and the market is monopolized by international pharmaceutical giants, so our country's medicines will always be stuck. The neck is always subject to people."
The price war behind immunotherapy drugs is a microcosm of the rise of Chinese medicine, and it is the first time that China has confronted international pharmaceutical giants in the field of innovative drugs.
After breaking the monopoly of international giants, China has become the country with the lowest price of PD1 drugs in the world, benefiting millions of families of cancer patients.
Zhang Yue said: "To be honest, there are many side effects of domestic drugs at present. Such drugs have entered the medical insurance and occupied the market. Good drugs with less side effects are forced to withdraw from the market. Isn't it a bit bad money driving out good money?"
Hu Jianjun pointed to the rice in the bowl: "If you don't do this, ordinary people can't even afford or buy medicines, so how can they talk about using good medicines? Just like when I was a child, I was grateful to God when I was full, □□that In the 1980s, the bark was eaten. How can you still pursue good food like you are now?
There are 1.4 billion people in the country, and the money for medical insurance is only a small amount. Every time the amount is exceeded, it is not the doctors themselves who pay the money.
We are a socialist country, and the interests of the masses come first. Medical insurance, medical insurance, must protect the majority of people. The state must allow the majority of people to afford medicines, and the second is to allow the majority of people to use better medicines.
One mouthful can’t make a fat man, you can’t have both fish and bear’s paw at present, how can you have both in the future? How to let ordinary people use better medicine? It is the responsibility of your generation. "
Zhang Yue suddenly felt inspired, and turned into admiring star eyes again: "Deputy Hu, I will work hard!"
"You? Just don't take your senior sister to play games." A doctor in the same department laughed, "I was sleeping in the duty room a few days ago, and I heard people beating and killing outside. I was so scared that I thought the doctor was in trouble. , I rushed out and saw that the seniors, sisters and brothers were sitting and playing games in the same posture!" He leaned back on the chair and imitated Zhang Yue's expressions and movements.
Everyone laughed, Hu Jianjun also smiled, and said: "Did you hear that, don't lose your mind."
Jian Qing and Zhang Yue nodded again and again, and the older generation of tutors began to recall the topic of Hu Jianjun just now, talking about how difficult it was to read and eat when they were young, and to teach young people to endure hardships and stand hard work, and study hard.
The accompanying young people listened to the truth, went back to the hotel, opened the literature, and worked hard for less than three minutes. Those who watched the drama watched the drama, the water flooded the water, and the phone porridge talked on the phone.
Lu Yinxi sent a message to Jian Qing, saying: 【Doctor Jian, the day after tomorrow is next month. 】
The two agreed to meet next month.
Jian Qing replied: [Itinerary has changed, I have to go to City H first. 】
After returning from City H, he went straight to work, and it took a few days before he could go to the University City.
Lu Yinxi did not return.
A few young people complained in a small group without a leader that the leader suddenly changed the itinerary. After returning to China, he had no vacation and could not accompany his partner. The partner was angry and didn't know how to coax him.
Jian Qing looked at it, blocked the group messages, and thought with a blank expression, what's the point of being angry? Who can stick to whom every day when they are adults? Such an object is not worth mentioning.
Lu Yinxi did not reply to the message for several minutes.
Jian Qing waited for a while, and realized it later
—Is she angry too?
The first thought that jumped to my mind was: how to explain it?
Jian Qing swiped to the small group again, unblocked it, and watched how the people in the group came up with ideas to coax people.
Another minute later, she received a reply message from Lu Yinxi: [I'm back, and I was suddenly dragged to make a cameo just now! Oh, it's okay, see you a few days later, city H is still very cold, remember to buy thicker clothes to wear. 】
Jian Qing replied with a "yes" and blocked the group chat again.
The author has something to say: Immunotherapy, pd1 and pdl-1 have been popularized in Chapter 6~
*small theater
Jane Double Standard Qing: If you are angry, don’t worry about it
Deer·Angry·Yinxi: (Delayed reply to messages...)
Jane Double Standard Qing: (Open the group chat, learn the experience of coaxing people)
References:
1. Literature
[1] Zhang Jianzhong. Fighting against PD-1 monoclonal antibody [N]. Medical Economic News, 2019-01-31 (F02).
2. Others (broker reports, web pages)
[1] Special Research Series IV of Yuekai Medicine: From the perspective of PD-1 (L1) monoclonal antibody innovative drugs to see the breakthrough of my country's innovative pharmaceutical companies; Author: Li Zhixin
[2] Hengrui Medicine In-depth Report: Innovative Craftsmen from a Global Perspective; Source: Soochow Research Institute
[3] The Involution of Domestic PD-1: Price War, Prisoner’s Dilemma, and the Disappearing 100 Billion Market; Author: Wu Jing